Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-03-06
1977-03-01
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2523011R, 526 21, A61K 4300
Patent
active
040102505
ABSTRACT:
The invention disclosed in this application is directed towards developing a radioiodination method which is applicable to the labeling of 2.02 micrometer (.mu.m) and 0.37 micrometer (.mu.m) diameter polyvinyltoluene latex particles that have been used as an immunoadsorbent. More particularly the overall method includes using an oxidation-reduction chemical reaction for tagging latex particles. Two methods are described. One, the hydrochloric acid method; and two, the nitric acid method.
REFERENCES:
patent: 3039977 (1962-06-01), Ingram
patent: 3853987 (1974-12-01), Dreyer
VAN Oss et al., "The Binding of Immune Globulins . . . Particles," Journal f the Reticuloendothelial Soc., vol. 3, pp. 29-40, (1966).
Keenan et al., General College Chemistry, Harper & Row, Pub., Inc., New York, 1957, p. 559.
Ho Chi Kuan
Parikh Gokaldas C.
Kyle Deborah L.
Montanye George A.
Padgett Benjamin R.
Sciascia Richard S.
The United States of America as represented by the Secretary of
LandOfFree
Radioactive iodine (125I) labeling of latex particles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioactive iodine (125I) labeling of latex particles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioactive iodine (125I) labeling of latex particles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1352991